Dexmedetomidine and HIPEC
Clinical trial NCT04106999 · UNKNOWN
Trial details
- NCT number
- NCT04106999
- Sponsor
- University of British Columbia
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.